Cochrane Abstracts
Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐IL‐5 Therapies for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431256/all/Anti‐IL‐5_therapies_for_chronic_obstructive_pulmonary_disease.
Anti‐IL‐5 therapies for chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431256/all/Anti‐IL‐5_therapies_for_chronic_obstructive_pulmonary_disease. Accessed November 24, 2024.
Anti‐IL‐5 therapies for chronic obstructive pulmonary disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431256/all/Anti‐IL‐5_therapies_for_chronic_obstructive_pulmonary_disease
Anti‐IL‐5 Therapies for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431256/all/Anti‐IL‐5_therapies_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
ID - 431256
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431256/all/Anti‐IL‐5_therapies_for_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
